Lynx1 Capital Management LP 13D and 13G filings for Pardes Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-23 4:23 pm Purchase | 2023-01-13 | 13G | Pardes Biosciences, Inc. PRDS | Lynx1 Capital Management LP | 3,139,202 5.000% | 3,139,202 (New Position) | Filing |